Medicine
Ivabradine 7.5 mg tablet
Ivabradine 7.5 mg tablet is a generic prescription medicine for oral use, made by 8 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store ivabradine tablets at 25ºC (77ºF), excursions permitted to 15ºC - 30ºC…
Key facts
- Active ingredient (INN)
- Ivabradine
- Brand
- Sold under the generic name
- Strength
- 7.5 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 180 tablets, 60 tablets, 500 tablets and 13 more
- Manufacturers
- Alembic PharmaceuticalsIndiaZydus LifesciencesIndiaNovadoz PharmaceuticalsIndiaCamber PharmaceuticalsIndiaBionpharmaGolden State Medical SupplyIngenus PharmaceuticalsNorthStar Rx
- Origin register
- US FDA, United States
- Storage
- Store ivabradine tablets at 25ºC (77ºF), excursions permitted to 15ºC - 30ºC (59ºF -86ºF).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- C01EB17 Ivabradine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 30 December 2021
- Identifiers
- RxCUI 1649485, 1649493DailyMed set ID 2e70f883-8c01-4ac2-815d-4a6d561c711a, 89134202-971b-4413-a9c9-d31a5c29722b, 5157767b-16d5-4a69-b6bd-95d360d19fda +7NDC 50742-363, 70710-1472, 72603-935 +7Application ANDA214051, ANDA213442, ANDA213483 +3
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 180 tablet, film coated in 1 bottle | 46708-680-45 | Alembic PharmaceuticalsIndia | 20 December 2024 |
| 60 tablet, film coated in 1 bottle | 46708-680-60 | Alembic PharmaceuticalsIndia | 20 December 2024 |
| 180 tablet, film coated in 1 bottle | 62332-680-45 | Alembic PharmaceuticalsIndia | 20 December 2024 |
| 60 tablet, film coated in 1 bottle | 62332-680-60 | Alembic PharmaceuticalsIndia | 20 December 2024 |
| 60 tablet in 1 bottle | 70710-1472-6 | Zydus LifesciencesIndia | 2 July 2024 |
| 180 tablet in 1 bottle | 70710-1472-8 | Zydus LifesciencesIndia | 2 July 2024 |
| 60 tablet in 1 bottle | 70771-1864-6 | Zydus LifesciencesIndia | 2 July 2024 |
| 180 tablet in 1 bottle | 70771-1864-8 | Zydus LifesciencesIndia | 2 July 2024 |
| 60 tablet, film coated in 1 bottle | 31722-054-60 | Camber PharmaceuticalsIndia | 5 October 2022 |
| 180 tablet, film coated in 1 bottle | 72205-337-18 | Novadoz PharmaceuticalsIndia | 1 July 2025 |
| 60 tablet, film coated in 1 bottle | 72205-337-60 | Novadoz PharmaceuticalsIndia | 1 July 2025 |
| 60 tablet, film coated in 1 bottle | 69452-191-17 | Bionpharma | 1 March 2025 |
| 500 tablet, film coated in 1 bottle | 69452-191-30 | Bionpharma | 1 March 2025 |
| 60 tablet, film coated in 1 bottle | 50742-363-60 | Ingenus Pharmaceuticals | 15 July 2024 |
| 60 tablet, film coated in 1 bottle | 51407-593-60 | Golden State Medical Supply | 29 August 2024 |
| 60 tablet, film coated in 1 bottle | 72603-935-01 | Northstar Rx | 1 July 2026 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Ivabradine 7.5 mg tablet.
Other strengths and forms of Ivabradine
Clinical summary
Ivabradine is a hyperpolarization-activated cyclic nucleotide-gated channel blocker indicated to reduce the risk of hospitalization for worsening heart failure in adult patients with stable, symptomatic chronic heart failure with reduced left ventricular ejection fraction. MedsAcross supplies Ivabradine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about IvabradineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Corlanor prescribing information (Amgen) · U.S. National Library of Medicine, DailyMed
- Corlentor: European public assessment report (EPAR) · European Medicines Agency
- Ivabradine Anpharm: European public assessment report (EPAR) · European Medicines Agency
Need Ivabradine 7.5 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.